Street Calls of the Week
Thomas David Hull III, President and CEO of Kewaunee Scientific Corp (NASDAQ:KEQU), sold 1,854 shares of common stock on September 29, 2025. The company, which has shown strong profitability with a 29.4% gross margin and impressive revenue growth of 30.1% over the last twelve months, has maintained solid financial health according to InvestingPro analysis. The shares were sold at a weighted average price of $43.42, for a total transaction value of approximately $80,500.
The price range for the shares sold was between $43.00 and $43.85
In other recent news, Kewaunee Scientific Corporation has announced the appointment of J. Jette Campbell to its Board of Directors, effective September 10, 2025. Campbell brings a wealth of experience from his previous roles at PepsiCo, Frito-Lay, and Griffin LLC, as well as his partnership at Carl Marks Advisors. This appointment was part of the company’s ongoing efforts to strengthen its leadership team. Additionally, during its Annual Meeting of Shareholders, Kewaunee Scientific re-elected Margaret B. Pyle and Donald F. Shaw as Class III directors for three-year terms. Pyle received 1,633,067 votes in favor, while Shaw secured 1,730,171 votes. The shareholders also approved the company’s auditor, reflecting continued confidence in the current leadership and operational strategies. These developments are part of Kewaunee Scientific’s recent efforts to ensure stability and experienced governance within the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.